Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Synovial cyst
ADR ID BADD_A04222
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.04      Synovial and bursal disorders
15.04.02      Synovial disorders
15.04.02.002      Synovial cyst
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.18      Soft tissue neoplasms benign
16.18.01      Soft tissue neoplasms benign NEC
16.18.01.004      Synovial cyst
Description A SYNOVIAL CYST located in the back of the knee, in the popliteal space arising from the semimembranous bursa or the knee joint. [MeSH]
MedDRA Code 10042858
MeSH ID D011151; D013581; D045888
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Baker's cyst | Ganglion | Ganglion and cyst of synovium, tendon, and bursa | Ganglion of joint | Ganglion of tendon sheath | Ganglion, unspecified | Other ganglion and cyst of synovium, tendon, and bursa | Synovial cyst | Synovial cyst of popliteal space | Synovial cyst, unspecified | Popliteal bursitis | Popliteal cyst | Ganglion cyst | Synovial hernia | Synovial hernia of femoral neck | Paralabral cyst | Popliteal Cyst | Cyst, Popliteal | Cysts, Popliteal | Popliteal Cysts | Baker's Cyst | Baker Cyst | Baker Cysts | Cyst, Baker | Cysts, Baker
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00061Alcohol--
BADD_D00066Alendronic acid0.000704%
BADD_D00151Apixaban0.000139%
BADD_D00284Bortezomib--
BADD_D00330Cabozantinib0.000246%
BADD_D00551Cyclosporine--
BADD_D00898Finasteride0.000220%
BADD_D01023Glimepiride0.000042%
BADD_D01119Ibrutinib0.000783%
BADD_D01243Lamotrigine0.000055%
BADD_D01252Leflunomide0.000643%
BADD_D01253Lenalidomide0.002363%
BADD_D01374Meloxicam--
BADD_D01401Metformin0.000008%
BADD_D01418Methotrexate0.000307%
BADD_D01564Nicotine0.001254%
BADD_D01654Palbociclib0.000112%
BADD_D01831Prednisolone0.000052%
BADD_D01834Prednisone0.000024%
BADD_D01835Pregabalin--
BADD_D01933Ribavirin0.003956%
BADD_D02100Sunitinib0.000112%
BADD_D02165Teriflunomide0.000651%
BADD_D02236Tofacitinib0.006172%
BADD_D02375Water--
BADD_D02407Upadacitinib0.001230%
BADD_D02412Octreotide--
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.001181%
The 1th Page    1    Total 1 Pages